Immunogenicity, safety, and compliance of high- and standard-strength four-dose hepatitis B vaccination regimens in patients receiving methadone maintenance therapy in China: a randomized, parallel-arm controlled trial

MediaIntel.Asia

You currently are not registered for any FirstWord Pharma services. About FirstWord Pharma | Upgrade Your FirstWord Pharma | Contact FirstWord Pharma | FirstWord ReportsAdvertise with FirstWord Pharma | Industry Partner ShowcaseAll Contents Copyright © 2021 Doctor's Guide Publishing Limited. All Rights Reserved.Terms of Use | Privacy Policy

This data comes from MediaIntel.Asia's Media Intelligence and Media Monitoring Platform.

Visit the original:
MediaIntel.Asia

Comments are closed.